WebBackground: Very preterm infants often require respiratory support and are therefore exposed to an increased risk of bronchopulmonary dysplasia (chronic lung disease) and later neurodevelopmental disability. Caffeine is widely used to prevent and treat apnea (temporal cessation of breathing) associated with prematurity and facilitate extubation. WebDefinition of terms. Apnoea : Absence of breathing for a period of >15 seconds often associated with a bradycardia and/or desaturation. Neonate: A newborn, up to 28 days of age (post-term). Periodic breathing : Three or more periods with no respiratory effort lasting 3 seconds or more in a 20 second period. This is a normal neonatal breathing ...
NICHD DASH - Eunice Kennedy Shriver National Institute of Child …
WebNov 13, 2024 · Study subjects will be patients in the NICU at one of the participating hospitals at a Neonatal Research Network site. Infants who meet the eligibility criteria will be randomized to either caffeine citrate at 10 mg/kg/dose or placebo (equal volume of all the excipients except for the active ingredient, caffeine citrate) to be given daily … WebTreatment continues until the infant is 34 to 35 weeks gestation and free from apnea requiring physical intervention for at least 5 to 7 days. Monitoring continues after the last episode of apnea or after caffeine has been stopped until the infant has gone 5 to 10 more days without having apnea requiring intervention. harry potter double letter names sporcle
Caffeine Citrate Prescribing Information - Drugs.com
WebJul 18, 2024 · Medication Summary. Caffeine citrate is currently the medication used in NICUs to treat apnea of prematurity (AOP). The specific mechanism is not known, but … WebJul 26, 2024 · Caffeine citrate is the drug of choice for the pharmacological treatment of apnea of prematurity. Factors such as maturity and genetic variation contribute to the interindividual variability in the clinical response to caffeine therapy in preterm infants, making the optimal dose administered controversial. Moreover, the necessity for … WebThe preventive effect of caffeine on apnea was significant in these infants. The relative risk for incidence of apnea in preterm neonates with a birth weight of <1200 g was 0.250 (95% confidence interval, 0.097-0.647). Only four infants (15.4%) in the caffeine group developed apnea, compared with 16 (61.5%) in the control group (p = 0.001). charles bronson home malibu